Lakefront Biotherapeutics NV (0JXZ.IL)
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of?various medicines for high unmet medical need.
24.32+0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-12.7%
The outlook
Lakefront Biotherapeutics NV currently reads as bearish based on below its 50- & 200-day averages, 17% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range17% of the way from its 52-week low to high
Market cap
$1.60B
52-wk high
32.70
52-wk low
22.62
50-day avg
25.07
200-day avg
26.46
Trailing P/E
—